SCHEMBL8309124

SCHEMBL8309124

OCCON=Cc1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.42
GAA P10253 2/20 0.38
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
JUN P05412 1/20 0.37
NFKB1 P19838 1/20 0.37
G6PC1 P35575 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
CTH P32929 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 1/20 0.34
ROCK2 O75116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309123 1.00 TAAR1 (0.42) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL8306343 0.81 TAAR1 (0.47) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL8306342 0.81 TAAR1 (0.47) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL8305938 0.80 TAAR1 (0.67) TAAR1SMN1; SMN2JUNNFKB1G6PC1
SCHEMBL8305934 0.80 TAAR1 (0.67) TAAR1SMN1; SMN2JUNNFKB1G6PC1
SCHEMBL14262702 0.78 PLA2G7 (0.45) SMN1; SMN2LMNACYP1A2L3MBTL1NPC1
SCHEMBL28210680 0.77 ATP1A1 (0.41) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL8308913 0.75 HDAC2 (0.54) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL8308910 0.75 HDAC2 (0.54) TAAR1GAAKMT2ASMN1; SMN2MEN1
SCHEMBL28210674 0.75 TAAR1 (0.38) TAAR1GAAKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed